2ESSB 5594 Information
| Legal Title | AN ACT Relating to reducing prescription drug costs by eliminating barriers impeding access to biosimilar medicines and interchangeable biological products; |
| Description | Concerning biosimilar medicines. (REVISED FOR ENGROSSED: Concerning biosimilar medicines and interchangeable biological products.) |
Details
Bill Topics
Committee Hearings
| Hearing | Senate Health & Long-Term Care (Public) |
| Hearing | Senate Health & Long-Term Care (Executive) |
| Hearing | House Health Care & Wellness (Public) |
| Hearing | House Health Care & Wellness (Public) |
| Hearing | House Health Care & Wellness (Executive) |
2ESSB 5594 Bill Timeline
Go to 2ESSB 5594 at leg.wa.gov
Introduced
SRules 3
HCW - Executive action taken by committee.
SRules 3
HCW - Majority; do pass.
SRules 3
Referred to Rules 2 Review.
SRules 3
Rules suspended.
SRules 3
Returned to second reading for amendment.
SRules 3
Rules Committee relieved of further consideration.
SRules 3
Placed on third reading.
SRules 3
By resolution, reintroduced and retained in present status.
SRules 3
By resolution, returned to Senate Rules Committee for third reading.
SRules 3
First reading, referred to Health Care & Wellness.
SRules 3
1st substitute bill substituted.
SRules 3
Floor amendment(s) adopted.
SRules 3
Rules suspended. Placed on Third Reading.
SRules 3
Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
SRules 3
Placed on second reading by Rules Committee.
SRules 3
Passed to Rules Committee for second reading.
SRules 3
HLTC - Majority; 1st substitute bill be substituted, do pass.
Ssubst for
First reading, referred to Health & Long-Term Care.